BFKN’s Corporate & Securities Group served as legal counsel to Elevate Beauty, an L Catterton platform, in connection with its investment in Eighth Day Skin, a luxury skincare brand that formulates products using bioidentical ingredients to support optimal skin health and beauty.

Launched exclusively at Violet Grey in 2021 by board-certified dermatologist and micrographic reconstructive skin cancer surgeon Dr. Antony Nakhla, Eighth Day made waves in the luxury skincare market with its proprietary skincare innovation, Peptide-Rich Plasma. Inspired by the innate healing and regenerative powers of human skin, Peptide-Rich Plasma is a patent-pending technology composed of 24 bioidentical peptides, growth factors, and amino acids that deliver potent benefits to the skin.

“Eighth Day has established itself as a beloved brand with cult products that harness the power of sophisticated, modern skin technology to promote timeless beauty. The brand has generated tremendous consumer loyalty by offering a narrow lineup of high-performance products that deliver real results,” said Jon Owsley, a managing partner in L Catterton’s Growth Fund.

BFKN's legal team was led by partners Andrew R. Grossmann and Megan Ratia and associate Victoria Rusanova Cordiak.

To read more about this deal, visit:

Jump to Page

We use cookies on our website to improve functionality and performance, analyze website traffic, and enable social media features. By continuing to use our website, you agree to our use of cookies.